Here are some of the largest recent moves: UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 4,994,433 shares (+63.4%) to their portfolio in Q3 2025, for an estimated $3,810,752,379 CAPITAL RESEARCH GLOBAL INVESTORS added 4,332,008 shares (+20.9%) to their portfolio in Q3 2025, for an estimated $3,305,322,104 PRICE T ROWE ASSOCIATES INC /MD/ removed 3,366,669 shares (-20.0%) from their portfolio in Q3 2025, for an estimated $2,568,768,447 CAPITAL WORLD INVESTORS removed 2,664,593 shares (-15.1%) from their portfolio in Q3 2025, for an estimated $2,033,084,459 JPMORGAN CHASE & CO removed 2,242,818 shares (-17.9%) from their portfolio in Q3 2025, for an estimated $1,711,270,134 GEODE CAPITAL MANAGEMENT, LLC added 1,689,260 shares (+9.3%) to their portfolio in Q3 2025, for an estimated $1,288,905,380 TIGER GLOBAL MANAGEMENT LLC removed 1,511,160 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,153,015,080 To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard
Thermal Considerations Heat plays a big role in internal resistance
Monitoring Required : For critical medications (e.g., warfarin, digoxin), monitoring blood levels and adjusting dosages may be necessary
When the receptor is engaged, it kicks off intracellular signaling cascades that drive both protein-building activity and cell proliferation
Conventional L-amino acid peptides of this size are degraded within minutes by serum proteases
